4.3 Review

The regulation of RANKL by mechanical force

Journal

JOURNAL OF BONE AND MINERAL METABOLISM
Volume 39, Issue 1, Pages 34-44

Publisher

SPRINGER JAPAN KK
DOI: 10.1007/s00774-020-01145-7

Keywords

Osteocyte; Osteoblast; Osteoclast; Mechanosensing; Mechanotransduction

Funding

  1. Japan Society for the Promotion of Science (JSPS)
  2. Japan Science and Technology Agency
  3. Japan Agency for Medical Research and Development (AMED), Advanced Research and Development Programs for Medical Innovation
  4. Daiichi Sankyo Foundation of Life Science
  5. Japan Rheumatism Foundation
  6. LIFE SCIENCE FOUNDATION OF JAPAN
  7. Lotte Research Promotion Grant
  8. Meiji Yasuda Life Foundation
  9. Mitsui Life Social Welfare Foundation
  10. Naito Foundation
  11. ONO Medical Research Foundation
  12. Suzuken Memorial Foundation
  13. Takeda Science Foundation
  14. Asahi Glass Foundation
  15. Ichiro Kanehara Foundation for the promotion of Medical Sciences and Medical Care
  16. Sumitomo Foundation
  17. Uehara Memorial Foundation
  18. TMDU
  19. Hisamitsu Pharmaceutical
  20. Secom Science and Technology Foundation (SSTF)
  21. Morikawakenkodo

Ask authors/readers for more resources

RANKL is a key mediator of osteoclast differentiation and bone resorption, regulated by various factors including mechanical forces. Mechanosensing proteins and mechanosignaling proteins on the cell membrane play essential roles in osteoblast differentiation and function through soluble factors.
Receptor activator of nuclear factor-kappa B ligand (RANKL) is a key mediator of osteoclast differentiation and bone resorption. Osteoblast-lineage cells including osteoblasts and osteocytes express RANKL, which is regulated by several different factors, including hormones, cytokines, and mechanical forces. In vivo and in vitro analyses have demonstrated that various types of mechanosensing proteins on the cell membrane (i.e. mechanosensors) and intracellular mechanosignaling proteins play essential roles in the differentiation and functions of osteoblasts, osteoclasts, and osteocytes via soluble factors, such as sclerostin, Wnt ligands, and RANKL. This section provides an overview of the in vivo and in vitro evidence for the regulation of RANKL expression by mechanosensing and mechanotransduction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available